{"url":"https://twitter.com/trvrb/status/1541548679898619904","author_name":"Trevor Bedford","author_url":"https://twitter.com/trvrb","html":"<blockquote class=\"twitter-tweet\"><p lang=\"en\" dir=\"ltr\">The <a href=\"https://twitter.com/US_FDA?ref_src=twsrc%5Etfw\">@US_FDA</a> VRBPAC committee will be meeting tomorrow to discuss variant-specific COVID-19 vaccines (<a href=\"https://t.co/Dm62X28f2K\">https://t.co/Dm62X28f2K</a>). Based on present observations, I would argue that the most important metric to optimize are titers against BA.4/BA.5 viruses. 1/10</p>&mdash; Trevor Bedford (@trvrb) <a href=\"https://twitter.com/trvrb/status/1541548679898619904?ref_src=twsrc%5Etfw\">June 27, 2022</a></blockquote>\n<script async src=\"https://platform.twitter.com/widgets.js\" charset=\"utf-8\"></script>\n\n","width":550,"height":null,"type":"rich","cache_age":"3153600000","provider_name":"Twitter","provider_url":"https://twitter.com","version":"1.0"}